Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 11 Breast Neoplasms 8 Neoplasms 3 Heart Failure 3 Lymphoma, Follicular 2 Heart Diseases 2 Cardiovascular Diseases 2 Ventricular Dysfunction, Left 1 Ventricular Dysfunction 1 Thoracic Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Obesity 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Metabolic Syndrome 1 Memory Disorders 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Dyspnea 1 Dyslipidemias 1 Diabetes Mellitus, Type 1 1 Cognitive Dysfunction 1 Central Nervous System Neoplasms 1 Cardiomyopathies 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Atherosclerosis 1

Interventions

Blood Specimen Collection 14 Nivolumab 13 Ipilimumab 12 pembrolizumab 11 trametinib 9 Surveys and Questionnaires 9 Gene Expression Profiling 9 dabrafenib 8 Biopsy 6 Specimen Handling 5 Immunotherapy 5 Immunohistochemistry 5 Amplified Fragment Length Polymorphism Analysis 4 encorafenib 3 binimetinib 3 atezolizumab 3 Restraint, Physical 3 Quality of Life 3 Polymerase Chain Reaction 3 Introns 3 Flow Cytometry 3 Drug Therapy 3 Data Collection 3 tremelimumab 2 pimonidazole 2 cobimetinib 2 aldesleukin 2 Watchful Waiting 2 Vemurafenib 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Melanoma × Echocardiography × Clear all

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡